Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

3.690 +0.240 (+6.96%)
Streaming Delayed Price Updated: 2:36 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,059,514
Open 3.510
Bid (Size) 3.680 (7)
Ask (Size) 3.690 (6)
Prev. Close 3.450
Today's Range 3.451 - 3.700
52wk Range 3.350 - 15.36
Shares Outstanding 76,232,192
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Performance

YTD
-69.53%
-69.53%
1 Month
-39.90%
-39.90%
3 Month
-59.93%
-59.93%
6 Month
-69.28%
-69.28%
1 Year
-72.44%
-72.44%

More News

Read More
Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
A Glimpse Into The Expert Outlook On Accolade Through 7 Analysts
Via Benzinga
Accolade Inc. (NASDAQ: ACCD) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm
From The Schall Law Firm
Via Business Wire
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q1 2025
Via InvestorPlace
Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024
Via InvestorPlace
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
From Accolade, Inc.
Via GlobeNewswire
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
Via InvestorPlace
Nasdaq Edges Higher; Cutera Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Gains Over 2%; TD SYNNEX Posts Downbeat Sales
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Healthcare Technology Company Accolade Shares Are Surging Today
Via Benzinga
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.